Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19 (Q28270486)

9 April 2017

1

L Bertilsson

0 references

author name string

Leif Bertilsson

series ordinal

1

1 reference

9 April 2017

language of work or name

English

0 references

publication date

September 1995

1 reference

Clinical Pharmacokinetics

9 April 2017

published in

1 reference

9 April 2017

volume

29

1 reference

9 April 2017

page(s)

192-209

1 reference

9 April 2017

issue

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199529030-00005

9 April 2017

exact match

0 references

cites work

Relationship between personality and debrisoquine hydroxylation capacity

1 reference

12 December 2020

Interindividual and interethnic differences in the demethylation and glucuronidation of codeine

1 reference

12 December 2020

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

1 reference

12 December 2020

Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification

1 reference

12 December 2020

A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin

1 reference

12 December 2020

Chromosomal assignment of human cytochrome P-450 (debrisoquine/sparteine type) to chromosome 22.

1 reference

12 December 2020

Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans

1 reference

12 December 2020

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

1 reference

12 December 2020

The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine

1 reference

12 December 2020

Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities

1 reference

12 December 2020

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations

1 reference

12 December 2020

The debrisoquine hydroxylation test predicts steady-state plasma levels of desipramine

1 reference

12 December 2020

Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe

1 reference

12 December 2020

The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.

1 reference

12 December 2020

Non-correlation between debrisoquine and metoprolol polymorphisms in the Venda

1 reference

12 December 2020

Biochemistry and molecular biology of the human CYP2C subfamily

1 reference

12 December 2020

Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics.

1 reference

12 December 2020

Low frequency of slow debrisoquine hydroxylation in a native Chinese population

1 reference

12 December 2020

Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians

1 reference

12 December 2020

Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.

1 reference

12 December 2020

Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidation

1 reference

12 December 2020

Genetic polymorphism of cytochrome P450 CYP2D6 in Zimbabwean population

1 reference

12 December 2020

Differences in diazepam pharmacokinetics in Chinese and white Caucasians--relation to body lipid stores.

1 reference

12 December 2020

Haloperidol concentrations elevated in Chinese patients

1 reference

12 December 2020

A methodological investigation on the estimation of the S-mephenytoin hydroxylation phenotype using the urinary S/R ratio

1 reference

12 December 2020

Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6

1 reference

12 December 2020

Ethnic differences in drug metabolism

1 reference

12 December 2020

Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype.

1 reference

12 December 2020

Ethnic differences in drug disposition and responsiveness

1 reference

12 December 2020

Pharmacokinetic and other related factors affecting psychotropic responses in Asians

1 reference

12 December 2020

Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.

1 reference

12 December 2020

S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

1 reference

12 December 2020

The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study

1 reference

12 December 2020

Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans

1 reference

12 December 2020

Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine

1 reference

12 December 2020

A predictive model for substrates of cytochrome P450-debrisoquine (2D6)

1 reference

12 December 2020

Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole.

1 reference

12 December 2020

Interethnic variation of drug metabolism

1 reference

12 December 2020

Correlations among the metabolic ratios of three test probes (metoprolol, debrisoquine and sparteine) for genetically determined oxidation polymorphism in a Japanese population

1 reference

12 December 2020

Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population

1 reference

12 December 2020

Disassociation between debrisoquine hydroxylation phenotype and genotype among Chinese

1 reference

12 December 2020

D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate

1 reference

12 December 2020

Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities

1 reference

12 December 2020

Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.

1 reference

12 December 2020

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

1 reference

12 December 2020

Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese

1 reference

12 December 2020

Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects

1 reference

12 December 2020

Debrisoquine hydroxylation polymorphism and personality

1 reference

12 December 2020

Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism.

1 reference

12 December 2020

Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19

1 reference

12 December 2020

Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis

1 reference

12 December 2020

Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6.

1 reference

12 December 2020

Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine

1 reference

12 December 2020

Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes

1 reference

12 December 2020

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 reference

12 December 2020

S-mephenytoin 4-hydroxylation in older Americans

1 reference

12 December 2020

Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.

1 reference

12 December 2020

Human cytochromes P450: problems and prospects

1 reference

12 December 2020

Inhibition of diazepam metabolism by fluvoxamine: a pharmacokinetic study in normal volunteers.

1 reference

12 December 2020

Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians

1 reference

12 December 2020

Hydroxylation of desmethylimipramine: dependence on the debrisoquin hydroxylation phenotype

1 reference

12 December 2020

In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase

1 reference

12 December 2020

Differences in drug metabolism polymorphism between Orientals and Caucasians

1 reference

12 December 2020

Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: interethnic differences in comparison with white subjects.

1 reference

12 December 2020

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test

1 reference

12 December 2020

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

12 December 2020

Genetically variable metabolism of antidepressants and neuroleptic drugs in man.

1 reference

12 December 2020

Diazepam effects and kinetics in Caucasians and Orientals

1 reference

12 December 2020

Haloperidol disposition is dependent on the debrisoquine hydroxylation phenotype: increased plasma levels of the reduced metabolite in poor metabolizers

1 reference

12 December 2020

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

1 reference

12 December 2020

Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in man

1 reference

12 December 2020

Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation

1 reference

12 December 2020

Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs

1 reference

12 December 2020

Desipramine pharmacokinetics in Chinese and Caucasian volunteers

1 reference

12 December 2020

A study of the debrisoquine hydroxylation polymorphism in a Nigerian population

1 reference

12 December 2020

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

1 reference

12 December 2020

Why are diazepam metabolism and polymorphic S-mephenytoin hydroxylation associated with each other in white and Korean populations but not in Chinese populations?

1 reference

12 December 2020

Stereoselective metabolism, pharmacokinetics and biliary elimination of phenylethylhydantoin (Nirvanol) in the dog

1 reference

12 December 2020

Neuroleptic dosage for Asians

1 reference

12 December 2020

Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism

1 reference

12 December 2020

Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population

1 reference

12 December 2020

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

1 reference

12 December 2020

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

1 reference

12 December 2020

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

1 reference

12 December 2020

Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals

1 reference

12 December 2020

Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms

1 reference

12 December 2020

Haloperidol and prolactin concentrations in Asians and Caucasians

1 reference

12 December 2020

10.2165/00003088-199529030-00005

Identifiers

DOI

2 references

9 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1768932

1024774000

0 references

1768932

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference